Cello World Q1 Results FY26: Q1 PAT Falls 11.58% to ₹73.02 Crore; Revenue Up 5.66% YoY

Cello World Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

Particulars	Quarter Ended
	30-06-2025	30-06-2024
Revenue from Operations	₹529.01	₹500.66
Profit Before Tax (PBT)	₹126.30	₹135.27
Profit After Tax (PAT)	₹73.02	₹82.58

(Figures in crores)

Cello World Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

Particulars	Quarter Ended
	30-06-2025	30-06-2024
Revenue from Operations	₹281.93	₹259.95
Profit Before Tax (PBT)	₹22.25	₹26.13
Profit After Tax (PAT)	₹16.04	₹16.76

(Figures in crores)

Cello World Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

• Cello World clocked Q1 FY26 consolidated revenue of ₹529.01 crores vs ₹500.66 crores. 
• On the profit front, Cello World earned a consolidated PAT of ₹73.02 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹82.58 crore. 
• Consolidated PAT fell for the first quarter of FY26, was 11.58% YoY, and revenue rose 5.66% YoY. 
• As per the standalone figures, the quarterly PAT of Cello World has decreased by 4.30%, and revenue has increased by 8.45% YoY.

Cello World Share Price Performance

On the opening bell of 12th August 2025, the shares of Cello World opened at ₹566.70 per share. However, the initial gains are wiped out as of now, and Cello World shares are trading at ₹563.75 per share, higher than their opening price. 

Considering the long-term performance, Cello World shares have yielded close to -38.05% returns in the past 1 year, and 5-year returns stand at -28.66%. Over the maximum timeframe, the Cello World share provided -28.66% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Cello World shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Also Read : Fortis Healthcare Q1 Results FY26: Q1 PAT Rises 56.83% to ₹260.28 Crore; Revenue Up 16.56% YoY

Recent Articles

HBL Engineering Q1 Results FY26: Q1 PAT Rises 78.87% to ₹143.27 Crore; Revenue Up 15.70% YoY

Fine Organic Q1 Results FY26: Q1 PAT Rose 7.04% to ₹117.10 Crore; Revenue Up 7.04% YoY

Eureka Forbes Q1 Results FY26: Q1 PAT Rises 20.32% to ₹38.68 Crore; Revenue Up 9.85% YoY

JM Financial Q1 Results FY26: Q1 PAT Rose 165.85% to ₹453.81 Crore; Revenue Up 3.18% YoY

IPCA Laboratories Q1 Results FY26: Q1 PAT Rises 21.31% to ₹233.21 Crore; Revenue Up 10.33% YoY